– Histocompatibility Supervisor, University of Alabama Birmingham, United States
Aim: This study evaluates the performance of the latest Luminex multiplex instrument; the xMAP INTELLIFLEX, in comparison to the FLEXMAP 3D platform for HLA antibody testing. Performance parameters assessed included analytical sensitivity, specificity, workflow efficiency, and data quality.
Methods: HLA antibody testing using Single Antigen Bead (SAB) assays (One Lambda/Thermo Fisher) was performed on both INTELLIFLEX and FLEXMAP 3D systems. To assess reproducibility and key performance characteristics, a single technologist performed testing on a set of 25 patient samples across three consecutive days. Results were analyzed and compared in median fluorescence intensity (MFI).
Results: The INTELLIFLEX demonstrated consistently higher positive control MFIs and more robust internal controls, improving confidence in antibody detection (Table 1):
These gains in sensitivity aligned with improved correlation with well characterized antibody specificities confirmed by positive T and B cell crossmatches (Figure 1).
The enhanced bead imaging on the INTELLIFLEX also contributed to better bead classification and data clarity, as demonstrated below (Table 2).
Workflow and instrument enhancements include: quicker acquisition times, a customizable user interface, a broader dynamic MFI range, and an integrated computer system. During our validation, we did not observe any issues such as low bead counts, XY platform failures, or syringe leaks.
Conclusion: The new INTELLIFLEX system delivers a substantial performance leap over the FLEXMAP 3D, with superior sensitivity, specificity, data confidence, and operational efficiency. These advancements position it as a cutting-edge solution ready to tackle the growing demands of modern histocompatibility and immunogenetics testing.
